Yongwoo David Seo

Yongwoo David Seo

University of Washington

H-index: 14

North America-United States

About Yongwoo David Seo

Yongwoo David Seo, With an exceptional h-index of 14 and a recent h-index of 14 (since 2020), a distinguished researcher at University of Washington, specializes in the field of Immunotherapy, Pancreatic cancer, Hepatobiliary cancer, Soft tissue sarcomas.

His recent articles reflect a diverse array of research interests and contributions to the field:

Intratumoral T-cell receptor repertoire composition predicts overall survival in patients with pancreatic ductal adenocarcinoma

Abstract CT030: Randomized placebo-controlled, biomarker-stratified phase 1b microbiome modulation trial for metastatic melanoma demonstrates impact of antibiotic pre …

Randomized Placebo-Controlled, Biomarker-Stratified Phase Ib Microbiome Modulation in Melanoma: Impact of Antibiotic Preconditioning on Microbiome and Immunity

Cancer testis antigen expression correlates with stromal natural killer cell activation and longer overall survival in small bowel neuroendocrine tumors

Spatial profiling reveals unique immune-transcriptomic features of tertiary lymphoid structures in melanoma

Identifying gut microbial determinants of clonal hematopoiesis of indeterminate potential (CHIP) in immunotherapy treated melanoma patients

Engraftment as a determinant of response in fecal microbiome transplantation interventions for immunotherapy in melanoma

A single dose of perioperative cefazolin disrupts the gut microbiome and immunity in patients (pts) with early-stage melanoma

Yongwoo David Seo Information

University

Position

___

Citations(all)

1275

Citations(since 2020)

937

Cited By

655

hIndex(all)

14

hIndex(since 2020)

14

i10Index(all)

15

i10Index(since 2020)

15

Email

University Profile Page

Google Scholar

Yongwoo David Seo Skills & Research Interests

Immunotherapy

Pancreatic cancer

Hepatobiliary cancer

Soft tissue sarcomas

Top articles of Yongwoo David Seo

Intratumoral T-cell receptor repertoire composition predicts overall survival in patients with pancreatic ductal adenocarcinoma

OncoImmunology

2024/12/31

Nicholas Borcherding
Nicholas Borcherding

H-Index: 15

Yongwoo David Seo
Yongwoo David Seo

H-Index: 10

Abstract CT030: Randomized placebo-controlled, biomarker-stratified phase 1b microbiome modulation trial for metastatic melanoma demonstrates impact of antibiotic pre …

Cancer Research

2024/4/5

Yongwoo David Seo
Yongwoo David Seo

H-Index: 10

Randomized Placebo-Controlled, Biomarker-Stratified Phase Ib Microbiome Modulation in Melanoma: Impact of Antibiotic Preconditioning on Microbiome and Immunity

Cancer Discovery

2024/4/4

Yongwoo David Seo
Yongwoo David Seo

H-Index: 10

Cancer testis antigen expression correlates with stromal natural killer cell activation and longer overall survival in small bowel neuroendocrine tumors

Cancer Research

2024/3/22

Spatial profiling reveals unique immune-transcriptomic features of tertiary lymphoid structures in melanoma

Cancer Research

2024/3/22

Identifying gut microbial determinants of clonal hematopoiesis of indeterminate potential (CHIP) in immunotherapy treated melanoma patients

Cancer Research

2024/3/22

Engraftment as a determinant of response in fecal microbiome transplantation interventions for immunotherapy in melanoma

Cancer Research

2024/3/22

A single dose of perioperative cefazolin disrupts the gut microbiome and immunity in patients (pts) with early-stage melanoma

Cancer Research

2024/3/22

Correlation of cancer testis antigen expression with high type-I interferon signal and prognosis in small bowel neuroendocrine tumors.

2024/1/20

Yongwoo David Seo
Yongwoo David Seo

H-Index: 10

Sarah Johnson
Sarah Johnson

H-Index: 2

Modulating a prebiotic food source influences inflammation and immune-regulating gut microbes and metabolites: insights from the BE GONE trial

EBioMedicine

2023/12/1

Toll-Like Receptor 4 Agonist Injection With Concurrent Radiotherapy in Patients With Metastatic Soft Tissue Sarcoma: A Phase 1 Nonrandomized Controlled Trial

JAMA oncology

2023/12/1

Efficacy of immune checkpoint inhibitors for the treatment of advanced melanoma in patients with concomitant chronic lymphocytic leukemia

Annals of Oncology

2023/9/1

Yongwoo David Seo
Yongwoo David Seo

H-Index: 10

Lydia Warburton
Lydia Warburton

H-Index: 6

Using gut microorganisms to treat cancer

Nature medicine

2023/8

Correlation of cancer testis antigen and interleukin expression with survival in small bowel neuroendocrine tumors.

2023/6/1

Yongwoo David Seo
Yongwoo David Seo

H-Index: 10

VirMAP for cancer: Characterization of the intratumoral virome in virally associated cancers and a resource for investigators.

2023/6/1

Yongwoo David Seo
Yongwoo David Seo

H-Index: 10

From bugs to drugs: Bacterial 3-IAA enhances efficacy of chemotherapy in pancreatic cancer

Cell Reports Medicine

2023/5/16

Blockade of interleukin 10 potentiates antitumour immune function in human colorectal cancer liver metastases

Gut

2023/2/1

Monitoring and Modulating Diet and Gut Microbes to Enhance Response and Reduce Toxicity to Cancer Treatment

2023/1/27

Yongwoo David Seo
Yongwoo David Seo

H-Index: 10

Quality of superior mesenteric and hepatic artery dissection in robotic pancreatoduodenectomy for pancreatic cancer

Journal of hepato-biliary-pancreatic sciences

2023/1

Preoperative therapy for pancreatic adenocarcinoma—precision beyond anatomy

2022/8/15

See List of Professors in Yongwoo David Seo University(University of Washington)